Free Trial

BioCorRx (BICX) Stock Price, News & Analysis

-0.01 (-1.23%)
(As of 05/20/2024 ET)
Today's Range
50-Day Range
52-Week Range
252 shs
Average Volume
1,072 shs
Market Capitalization
$7.69 million
P/E Ratio
Dividend Yield
Price Target
BICX stock logo

About BioCorRx Stock (OTCMKTS:BICX)

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.

BICX Stock Price History

BICX Stock News Headlines

BioCorRx Inc. (BICX)
BioCorRx Reports Business Update for 2023
TAYNX Transamerica High Yield ESG-Class R4
Cheng Fwa Industrial Ltd (5426)
Tokai Holdings Corp (3167)
Fukui Bank Ltd (8362)
Nissha Printing Co Ltd (7915)
DSC Investment Inc (241520)
See More Headlines
Receive BICX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioCorRx and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Fiscal Year End

Industry, Sector and Symbol

Specialty outpatient clinics, not elsewhere classified
Current Symbol
Year Founded


Net Income
Net Margins
Pretax Margin


Sales & Book Value

Annual Sales
Book Value
($1.14) per share


Free Float
Market Cap
$7.69 million
Not Optionable
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Ms. Lourdes Felix (Age 56)
    CEO, CFO & Director
    Comp: $250k
  • Mr. Louis Charles Lucido (Age 76)
    President & Director
    Comp: $60k
  • Dr. George N. Fallieras
    Medical Consultant

BICX Stock Analysis - Frequently Asked Questions

How have BICX shares performed in 2024?

BioCorRx's stock was trading at $0.78 at the beginning of the year. Since then, BICX shares have increased by 2.6% and is now trading at $0.80.
View the best growth stocks for 2024 here

Are investors shorting BioCorRx?

BioCorRx saw a increase in short interest in April. As of April 15th, there was short interest totaling 800 shares, an increase of 100.0% from the March 31st total of 400 shares. Based on an average trading volume of 2,800 shares, the short-interest ratio is presently 0.3 days.
View BioCorRx's Short Interest

How were BioCorRx's earnings last quarter?

BioCorRx Inc. (OTCMKTS:BICX) released its earnings results on Wednesday, May, 15th. The company reported ($0.14) EPS for the quarter.

What other stocks do shareholders of BioCorRx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BioCorRx investors own include Mondi (MNDI), Alkermes (ALKS), Editas Medicine (EDIT), ImmunoGen (IMGN), Intel (INTC), Netflix (NFLX), Nektar Therapeutics (NKTR), Oracle (ORCL), SS&C Technologies (SSNC) and AT&T (T).

How do I buy shares of BioCorRx?

Shares of BICX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:BICX) was last updated on 5/21/2024 by Staff

From Our Partners